Skip to main content icon/video/no-internet

IN VITRO FERTILIZATION (IVF) involves the combination of an unfertilized oocyte and spermatozoa in a Petri dish to allow fertilization to occur. Subsequent cleavage of the newly formed zygote can be supported in vitro by various culture conditions. Transfer of embryos into the uterus has resulted in pregnancy and live births in many mammalian species. Embryos cultured to the blastocyst stage have provided a source for embryonic stem cells. Embryonic stem cells have the capacity to renew and to differentiate into many cells of the body, a term known as potency. Therefore, in vitro fertilization provides a clinical application for infertility issues as well as a research avenue to understand early development.

Although the process of reproduction has been of interest to both science and philosophy since Aristotle's time, the first example of in vitro fertilization was shown by Lazaro Spallanzani (1729–99) when he demonstrated that tadpoles only developed if oocytes came into contact with semen. Much later, Yanagimachi and Chang (1963) reported the fertilization of hamster oocytes with capacitated sperm which prefaced the successes in human in vitro fertilization. The first live birth from human in vitro fertilization was in 1978, by Patrick Steptoe and Robert Edwards in the United Kingdom. Since then, the in vitro fertilization procedure has become a routine treatment option for patients dealing with infertility.

In vitro embryo culture has helped researchers identify markers associated with pluripotency such as Oct-4.

Procedure

The first step in the in vitro fertilization process involves the superovulation of the female. In current paradigms, this entails the down—regulation of gonadotrophic—releasing hormone from the hypothalamus which suppresses the anterior pituitary from secreting the gonadotrophins: follicle stimulating hormone and luteinizing hormone. This results in a temporary state of hypogonadotrophic hypogonadism. Once this state is reached, gonad—otrophin stimulation can begin by the administration of follicle stimulating hormone to induce follicle growth in the ovaries. During this time, follicle growth is monitored via ultrasound and by peripheral blood levels of estradiol.

Once follicle size and estradiol levels have reached the desirable size and levels, respectively, human chorionic gonadotrophin is given for ovulation induction. Ovulation in normal cycles is preceded by a surge in luteinizing hormone. Since the β-subunit of human chorionic gonadotrophin is similar to that of luteinizing hormone, human chorionic gonadotrophin is often used in lieu of luteinizing hormone. Once ovulation has been induced, oocyte collection is scheduled to occur within 36 hours postinjection. This 36-hour window is critical because during this time, the oocytes within the follicles will reinitiate meiosis II and will progress to metaphase II.

During oocyte collection, semen will be obtained by masturbation and will be processed typically by gradient centrifugation to remove the seminal plasma and debris. Next, the oocytes and sperm will be combined in a Petri dish to undergo fertilization. An alternative approach is to perform intracytoplasmic sperm injection where an isolated sperm cell is injected into each oocyte. This helps the sperm bypass the zona pellucida of the oocyte and results in high rates of fertilization. Successful fertilization is evidenced by the appearance of two pronuclei in the oocyte at approximately 16–18 hours postinsemination. The pronuclei are said to come into syngamy where the nucleus from the oocyte comes into close proximity with the nucleus from the spermatocyte.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading